Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty  by Klein, Lloyd W. et al.
JACC Vol. 17, No.3 
March 1, 1991:621-6 
621 
Incidence and Clinical Significance of Transient Creatine Kinase 
Elevations and the Diagnosis of Non-Q Wave Myocardial Infarction 
Associated With Coronary Angioplasty 
LLOYD W. KLEIN, MD, FACC, BARRY L. KRAMER, MD, FACC, ELIZABETH HOWARD, RN, 
MICHAEL LESCH, MD, FACC 
Chicago, Illinois 
To assess the incidence and clinical significance of elevated total 
plasma creatine kinase (CK) and MB isoenzyme fraction after 
apparently successful coronary angioplasty, a prospective study of 
272 consecutive elective procedures was undertaken. Total CK 
(normal <200 IV/liter) and CK MB isoenyzme (normal ::s4%) 
were measured immediately after successful completion of the 
procedure and every 6 h for 24 h. All nonelective procedures and 
results not fulfilling all American Heart Association/American 
College of Cardiology Task Force guideline criteria for a success-
ful result were excluded from analysis. 
Of the 272 elective procedures, 249 (92%) were successful; 
abnormally elevated CK or CK MB serum levels, or both, were 
found in 38 (15 %) of the successful outcomes. Three patterns 
of abnormal enzymes were identified: 15 patients with CK 
2:200 IV/liter and CK MB 2:5% (group 1), 4 patients with CK 
2:200 IV/liter and CK MB ::s4% (group 2) and 19 patients with 
The acute closure of an epicardial coronary artery during 
percutaneous transluminal coronary angioplasty is caused 
by intimal dissection, thrombosis, spasm or some combina-
tion. The clinical manifestation of this event may be death, 
arrhythmia or severe myocardial ischemia. Acute vessel 
closure resulting in either emergency bypass surgery or Q 
wave myocardial infarction occurs in roughly 5% to 15% of 
patients, depending on patient selection, stenosis morphol-
ogy and operator experience (1). 
In contrast to these major complications of coronary 
angioplasty, the causes, incidence and clinical significance of 
acute non-Q wave myocardial infarction complicating coro-
nary angioplasty have not been the subject of any prior 
series. This is surprising given the numerous studies empha-
sizing the short- and long-term features of spontaneous 
non-Q wave infarction (2) and the significance of smaller 
From the Cardiology Section, Department of Medicine, Northwestern 
Memorial Hospital and Northwestern University Medical School, Chicago, 
Illinois. 
Manuscript received May 7, 1990; revised manuscript received September 
13, 1990, accepted September 26, 1990. 
Address for reprints: Lloyd W. Klein, MD, Rush-Presbyterian-St. Luke's 
Medical Center, lelke Pavilion. 10th Floor, 1653 West Congress Parkway, 
Chicago, Illinois 60612. 
© 1991 by the American College of Cardiology 
CK <200 IV/liter and CK MB 2:5% (group 3). The three groups 
were distinguishable by the nature of the complications causing 
the enzyme release (in particular, the etiology and clinical mani-
festations). There were significantly more clinically apparent 
events in group 1 than in the other groups (13 of 15 versus 11 of 
23, P < 0.01) and more events associated with persistent electro-
cardiographic changes (p = 0.05) and chest pain (p < 0.05). 
However, no clinically important sequelae were recognizable in 
any group at hospital discharge. 
Thus, abnormal cardiac serum enzyme release after appar-
ently successful coronary angioplasty is 1) relatively common; 2) 
has many possible causes, including both minor complications and 
early reversibility of impending major complications; and 3) 
results in no permanent clinical sequelae. 
(J Am Coil CardioI1991;17:621-6) 
elevations of cardiac serum enzymes (3). Furthermore, the 
frequency with which abnormally elevated cardiac serum 
enzymes are observed after successful angioplasty is un-
known. Another clinically relevant issue is the relation 
between serum creatine kinase (CK) elevations and transient 
balloon occlusion. Heyndrickx et al. (4) showed conclu-
sively in a baboon model that CK release may occur after 
short periods of coronary occlusion without myocardial 
necrosis. Thus, the mere occurrence of elevated serum 
enzyme levels may not be sufficient to infer the diagnosis of 
myocardial infarction in this setting. 
Methods 
Study patients. All patients undergoing elective single or 
multivessel coronary angioplasty at Northwestern Memorial 
Hospital between March 1989 and February 1990 were 
considered candidates for this study. The study group con-
sisted of those patients with successful elective angioplasty 
of at least one coronary stenosis, as defined by both clinical 
and angiographic criteria. All patients with major in-hospital 
complications, including death, resuscitation from cardiac 
arrest, Q wave myocardial infarction and emergency bypass 
surgery, were excluded from analysis. Any patient with 
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prolonged hypotension or prolonged ischemia, or both, 
unresponsive to usual medical measures and necessitating 
bypass surgery or resulting in Q wave infarction were 
excluded under these criteria. In addition, patients undergo-
ing cardiac catheterization during acute myocardial infarc-
tion or for postinfarction angina within 36 h of symptom 
onset were excluded on the basis of elevated serum cardiac 
enzyme levels before angioplasty, as were patients not 
meeting the definition of a successful angioplasty result. 
Thus, all patients believed by their physicians to have had a 
successful elective procedure were entered into the study 
group on a prospective basis. Patients whose subsequent 
clinical course necessitated a return to the catheterization 
laboratory within 72 h for further interventional procedures 
were excluded. 
A successful angioplasty result was that defined by the 
American Heart Association/American College of Cardiol-
ogy Task Force on angioplasty (1) and as applied by our 
group previously (5). The criteria used were: 1) no in-
hospital complications; 2) improvement in luminal diameter 
narrowing to <50% of a contiguous normal vessel; and 3) 
complete resolution of clinical manifestations of ischemia 
after coronary angioplasty. 
Protocol. Electrocardiographic (ECG) monitoring of at 
least two noncontiguous ECG leads was performed during 
angioplasty. Acute ST and T wave changes, heart rate and 
blood pressure were continuously recorded throughout the 
procedure. Detailed procedural notes of the occurrence, 
severity and duration of chest pain and ECG changes were 
recorded by both independent laboratory staff and the cath-
eterization team. In addition to routine follow-up study by 
the operators, a nurse clinician examined and questioned 
each patient. The nurse clinician assured that all appropriate 
follow-up blood specimens and ECGs were obtained for up 
to 72 h after angioplasty. An ECG was obtained immediately 
after angioplasty and on the next 2 mornings routinely; other 
ECGs were performed as deemed clinically necessary. ST 
segment or T wave changes, or both, that were clearly new 
compared with preangioplasty baseline data, were (in the 
absence of subsequent Q wave development) considered 
clinical events if they persisted for 2::48 h or until hospital 
discharge. 
Angiographic and clinical observations. All coronary an-
giograms were reviewed by two investigators. Percent lumi-
nal narrowing of all dilated stenoses was measured according 
to the caliper method before and after angioplasty. In 
addition, a notation was made of any complication, accord-
ing to the following criteria. Intimal dissection was defined 
as the angiographic appearance of either a negative intralu-
minal radiolucency consistent with an intimal flap or subin-
timal contrast staining that persisted after free flow of 
contrast medium through the vessel (5). In all cases in which 
the abnormal enzyme release was ascribed to intimal dissec-
tion, there had to be clinical or angiographic evidence, or 
both, of transient, actual or impending vessel closure neces-
sitating reopening by pharmacologic or mechanical means, 
or both. Thrombus was defined as an ovoid filling defect, 
with or without contrast staining, that appeared within the 
lumen. Graft embolism was defined as the visualization of 
transient or permanent small branch occlusion during angio-
plasty of a saphenous vein graft 2::6 years old. Spasm was 
considered present when a subtotal or total occlusion lasting 
for several minutes occurred in association with a clinical 
event that completely resolved after sublingual, intravenous 
or intracoronary nitroglycerin administration. Branch occlu-
sion was defined as transient or permanent occlusion of a 
minor or major branch of the epicardial vessel observed on 
the preangioplasty angiogram at any time during angioplasty. 
Clinical events were defined as either chest pain or the 
observation of acute ECG changes persisting without signif-
icant diminution for 2::3 min after deflation of the balloon and 
requiring medical therapy. In addition, whether or not these 
occurrences correlated with angiographic events during the 
course of the procedure was recorded. The vessel responsi-
ble for the enzyme increase was determined prospectively, 
and for purposes of data analysis, checked retrospectively 
by correlation with angiographic and ECG changes. 
Cardiac enzyme and isoenzyme determinations. Both CK 
and CK MB isoenzyme fractions were prospectively mea-
sured in all study patients. At least one normal determination 
before angioplasty was required for study entry; in patients 
with recent (that is, within the preceding 72 h) myocardial 
infarction, at least two sets with a total CK <120 IUlliter and 
CK MB isoenyzme fraction <4% in the preceding 24 h were 
required for study qualification. Blood samples for both CK 
and CK MB measurements were drawn within 1 h after 
angioplasty and then every 6 h for four more determinations. 
Total CK activity (normal <200 IUlliter). This was ana-
lyzed by the Technicon RA-lOOO commercial technique. The 
CK MB isoenzyme values were determined by agarose gel 
electrophoresis with fluorometric quantification. Results of 
the isoenzyme measurements were expressed as a percent of 
total enzyme activity (normal ::::::4%) (3). 
Patient groups. Patients were candidates for this study if 
they fulfilled all of the previously noted entry criteria and 
exhibited at least two abnormal determinations of either total 
CK or CK MB isoenzyme, or both. Three patterns of 
abnormal enzyme and isoenzyme levels were detected. 
Group 1 included patients in whom at least two sets with CK 
2::200 IU/liter and CK MB fraction 2::5% were noted. Group 
2 comprised patients with elevation of total CK whose CK 
MB fraction remained within normal limits. Group 3 con-
sisted of those patients with only CK MB fraction elevation 
without total CK elevation. In all cases, these increases were 
transient and either completely normalized or showed a 
definite trend toward normalization after 48 h. For purposes 
of data analyses, the highest total CK value and the CK MB 
fraction associated with it were recorded. 
Statistical methods. Continuous data were expressed as 
mean values ± SD. Comparisons among the three groups 
were performed using analysis of variance techniques 
(ANOY A). Subgroup comparisons were allowed only if 
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p < 0.1 (ANOVA). Comparisons between two groups were 
made using the chi-square test in the case of discrete data 
and the two sample t test in the case of continuous data. A 
p value <0.05 was considered to be statistically significant. 
Results 
Patient selection. Between the inclusive study dates, 305 
consecutive coronary angioplasty procedures were per-
formed. Of these, 33 were performed either during or early 
after acute myocardial infarction and were excluded (as 
defined in Methods). Of the remaining elective procedures, 
there was 1 procedural death (0.4%), II acute vessel clo-
sures necessitating immediate coronary bypass surgery 
(4%), 6 additional Q wave myocardial infarctions occurring 
within 48 h of the procedure (2.2%), 4 unsuccessful results 
due to an impassable chronic total occlusion (1.5%) and I 
inadequate dilation (0.4%). Thus, 249 (92%) of 272 elective 
procedures were considered successful by all angiographic 
and clinical criteria. Total plasma CK and CK MB isoen-
zyme fraction were determined according to the protocol in 
all patients. 
Distribution of cardiac enzyme elevation. Abnormally 
elevated total CK or CK MB isoenzyme fraction, or both, 
was noted in 38 (15%) of the 249 patients and these patients 
formed the study group. The mean age of this group was 
62 ± 11.2 years (range 40 to 87); 25 were men and 13 women. 
Thirty (79%) of the 38 patients underwent angioplasty of 
either two or three epicardial vessels or their branches; in 
contrast, multi vessel angioplasty was performed in only 43% 
of the 211 patients without enzyme elevation (chi-square = 
15.1, p < 0.0001). 
Coronary angiographic findings revealed that the vessel 
responsible for the index enzyme increase was the left 
anterior descending coronary artery in 14 (37%), the right 
coronary artery in 20 (53%) and the left circumflex coronary 
artery in 2 (5%); in 2 additional patients, the vessel involved 
could not be determined. Angioplasty of a saphenous vein 
graft resulted in an enzyme increase in four patients (two 
anterior descending, one circumflex, one right coronary 
artery) and these cases were included for analysis. 
The mean total peak CK in the entire 38 patient study 
group was 221 IV/liter (range 127 to 475). Similarly, the 
mean CK MB isoenzyme determination accompanying the 
peak CK was 8.9% (range 0% to 20%). 
Clinical and angiographic correlation (Table 1). Nineteen 
(50%) of the 38 patients had prolonged chest pain during the 
angioplasty procedure. In addition, seven other patients had 
distinct episodes of ischemic chest pain at some time in the 
subsequent 72 h after the angioplasty procedure; altogether, 
26 (68%) of the 38 patients had some prolonged chest pain 
related to the angioplasty procedure. Twenty-one patients 
(55%) had ECG changes persisting >3 min after balloon 
deflation. Persistent ST and T wave changes were observed 
at follow-up study and were present at hospital discharge in 
18 patients (47%). Both chest pain and ECG changes during 
Table 1. Selected Clinical Manifestations of an Increase in 
Cardiac Enzyme Levels in 38 Patients 
Serum Levels 
Group I Group 2 Group 3 
(n = 15) (n = 4) (n = 19) 
Apparent clinical event 13 (87%) I (25%) 10 (53%) 
(during PTCA)* 
Chest pain 14 (93%) 2 (50%) 10 (53%) 
(during or after 
PICA)t 
Persistent ECG 10 (67%) 0(0%) 8 (42%) 
changes* 
*p < 0.05 (ANOV A); p < 0.05 by chi-square analysis (group I versus 
group 3) and p < 0.01 (group I versus groups 2 and 3). tp < 0.08 (ANOVA); 
p < 0.03 by chi-square analysis (group I versus groups 2 and 3). tp < 0.05 
(ANOVA); p = 0.05 by chi-square analysis (group I versus groups 2 and 3). 
See text for other manifestations tested; no others were significantly different 
between groups. ECG = electrocardiographic; PICA = percutaneous trans-
luminal coronary angioplasty. 
angioplasty occurred in 15 patients (40%). Three (8%) of the 
38 patients had hypotension (systolic blood pressure 
<80 mm Hg) and 5 patients had an arrhythmia associated 
with the acute clinical event. This included premature ven-
tricular complexes in two patients, atrioventricular block 
and premature ventricular complexes in one patient, nons us-
tained ventricular tachycardia in one and intermittent left 
bundle branch block in one. 
Altogether. 24 (63%) of the 38 patients had an apparent 
clinical event that occurred in the catheterization laboratory. 
The cause of the abnormal enzyme increase could be deter-
mined or inferred angiographically in 26 patients (Table 2). 
This included coronary branch occlusion in 7 patients, 
intimal dissection with transient vessel closure in II, saphe-
nous vein graft embolism in 4 patients, coronary spasm in 2 
and thrombosis in 2. 
Thirty-seven of the 38 study patients were discharged 
within 5 days of the angioplasty procedure without further 
invasive or operative procedures. One patient had a pro-
longed clinical course due to presumed allergy to a medica-
tion. 
Analysis by enzyme elevation pattern. The 38 patients 
with an abnormal increase in cardiac enzyme were further 
subclassified by the pattern of enzyme elevations, as defined 
under Methods. Fifteen patients formed group 1, 4 were 
Table 2. Cause of Abnormal Cardiac Serum Enzyme Elevation in 
38 Patients 




Saphenous vein graft embolism 
Unknown 
Group I 
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included in group 2 and 19 fulfilled the criteria for group 3. 
There were no significant differences among these three 
groups regarding age, gender or artery undergoing angio-
plasty. 
When patients with both total CK and CK MB isoenzyme 
elevations were compared with those with only a single 
abnormal determination (Table 1), patients in group 1 had a 
significantly higher number of apparent clinical events (87% 
versus 48%) as compared with groups 2 and 3 (p < 0.01). 
Chest pain was more frequent either during or after angio-
plasty (p < 0.05) and more persistent ECG changes 
(p = 0.05) in group 1 than in the other groups. 
Importantly, there was a statistically significant differ-
ence between groups 1 and 3 in terms of the occurrence of a 
clinical event in the laboratory. Fifteen (87%) of the 18 group 
1 patients had an obvious clinical event, whereas only 10 
(53%) of the 19 group 3 patients had an event (p = 0.03). 
Notably, all three episodes of hypotension and all five 
episodes of significant arrhythmias occurred in situations 
marked by both a clinically apparent event and abnormal CK 
MB isoenzyme elevation (group 3). 
In addition, the etiology of the clinical event was clearly 
different among the three groups. The occurrence of side 
branch occlusion was more likely in group 1 (5 of 15 versus 
2 of 23), whereas the occurrence of intimal dissection was 
more frequent in group 3 (7 of 19 versus 4 of 19). Of the 
seven patients with side branch occlusion, all five with both 
CK and CK MB isoenzyme elevation had involvement of 
relatively larger branches noted to be closed at some time 
during the angioplasty procedure, whereas in the two pa-
tients with only abnormal CK MB isoenzyme but normal 
total CK, the occlusion was due to either a small septal or a 
small marginal branch closure and was only identified when 
the cine film was reviewed. Similarly, in those intimal 
dissections with only CK MB isoenzyme elevation, antero-
grade flow was reestablished more quickly than in group 1. 
Discussion 
This study was undertaken primarily to describe and 
characterize the incidence and clinical importance of cre-
atine kinase (CK) and CK MB isoenzyme release after an 
apparently successful coronary angioplasty procedure. A 
related but separate objective was to draw a distinction 
between inconsequential enzyme release, perhaps as a result 
of mUltiple or prolonged arterial balloon occlusions, and the 
occurrence of non-Q wave infarction resulting from minor or 
transient periprocedural complications. Yet another issue is 
the possibility of false-positive data supplied by a highly 
respected clinical laboratory and its potential impact on 
subsequent patient management. Finally, questions arise 
concerning the necessity to routinely monitor cardiac serum 
enzymes after an apparently successful coronary angioplasty 
procedure and the relevance of abnormal findings to short-
term outcome. 
Cardiac serum enzyme elevation and clinical events after 
successful angioplasty. The results of this investigation sug-
gest that modestly elevated total CK and CK-MB fractions 
occur frequently and unpredictably after a coronary angio-
pia sty procedure fulfilling both clinical and angiographic 
criteria for success. In the current study, 15% of all success-
ful procedures performed over a 10 month study period were 
associated with at least one enzymatic criterion suggestive of 
myocardial necrosis. An apparent clinical event was identi-
fied in 63% of these cases, suggesting that events currently 
judged by interventionists (6,7) as having little permanent 
clinical sequelae nevertheless are associated with myocar-
dial necrosis and non-Q wave myocardial infarction. The 
majority of the cases in which enzyme release occurred were 
associated with an episode of prolonged chest pain or ECG 
changes, or both. Such events were often due to transient 
closure of a major vessel as a result of dissection, spasm or 
thrombosis, but were also associated with side branch oc-
clusion or saphenous vein graft embolization. 
Cardiac serum enzyme elevation without a clinical event. 
Notably, a minority of cases with serum enzyme elevation 
had no clinically distinguishable event. Whether or not these 
cases represent merely laboratory error or enzyme release 
due to repetitive or prolonged vessel occlusion, or both, 
without necrosis (3), increased enzyme washout or early 
detection of a minor degree of myocardial necrosis (8,9) is 
ultimately unanswerable. However, the data do yield several 
interesting observations in this regard. Creatine kinase MB 
isoenzyme elevation alone was associated with a signifi-
cantly lower incidence (53%) of identifiable clinical events 
than was elevation of both total CK and CK MB fraction 
(87%) (p < 0.05). This observation suggests that abnormal 
levels of both enzymes (group 1) may more specifically 
identify true necrosis. Importantly, all three episodes of 
symptomatic hypotension and all five episodes of arrhyth-
mias occurred in association with an identifiable event and 
abnormal CK MB isoenzyme elevation. 
Clinical consequences of asymptomatic cardiac serum en-
zyme elevation. Eighteen (47%) of these patients had persist-
ent ECG changes as a result of an event during coronary 
angioplasty. Nevertheless, there were no major subsequent 
cardiac in-hospital complications in any of the 38 patients in 
the study. Although it is apparent from these observations 
that no alteration in patient management is warranted on the 
basis of asymptomatic enzyme elevation alone, subsequent 
strategies may be appropriately tailored to this group of 
patients. Clinical decisions may be particularly facilitated 
when the etiology of the event and the potential for subse-
quent myocardial jeopardy based on angiographically de-
fined anatomy are known. The major conclusion to be drawn 
from this study is that, although small enzyme elevations, 
often associated with a minor clinical event during angio-
plasty, may result in persistent ECG changes or brief epi-
sodes of chest pain, or both, no apparently important clinical 
consequences are apparent after several days. 
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Previous studies. The finding that a minority of appar-
ently successful coronary angioplasty procedures are asso-
ciated with abnormal enzyme elevations but not with in-
creased in-hospital morbidity or mortality is remarkably 
similar to the results of Oh et al. (10), who retrospectively 
analyzed the data from 128 patients in the early years of 
angioplasty (1979 to 1982). Although their data are interest-
ing primarily from a historical perspective, it is noteworthy 
that the investigators found a 20% incidence of abnormal CK 
MB isoenzyme elevation. However, the fact that theirs was 
not a prospective consecutive series limits the study conclu-
sions, as reflected by the timing of cardiac serum enzyme 
determinations, the absence of preangioplasty enzyme mea-
surements and the exclusion of 15% of otherwise eligible 
patients because serial enzyme levels were not measured. 
Additionally, clinical and angiographic observations are far 
more sophisticated now than they were more than a decade 
ago, a factor that undoubtedly had an impact on the study 
results. 
The study by Heyndrickx et al. (4), in which 15 min 
periods of coronary artery occlusion in baboons and their 
effects on plasma CK MB isoenzyme activity were studied, 
points out some of the specific difficulties of analyzing 
increases in enzyme levels in the angioplasty model. In their 
study, the effect of 15 min of balloon occlusion resulted in 
significant increases in total CK and CK MB fraction levels. 
Yet, at autopsy, neither gross pathologic nor histologic 
evidence of myocardial necrosis was observed. This obser-
vation is directly applicable to coronary angioplasty in 
human patients in whom brief episodes of ischemia are 
produced and hence it is possible that some cases may be 
associated with increased serum enzyme activity. There is 
also indirect evidence to suggest that transient ischemic 
episodes not accompanied by myocardial necrosis may be 
associated with enzyme leakage. Chiong et al. (11) reported 
small but significant CK release in the coronary sinus during 
pacing-induced ischemia in patients with coronary stenosis. 
In addition, small amounts of enzymes may leak from 
myocardial cells during stress, tachycardia and exercise. 
Fishbein (12), commenting on the study of Heyndrickx et al. 
(4), stated that it is possible that reversible myocardial injury 
in the absence of cell death can result in alterations of 
membrane permeability with resultant release of myocardial 
enzymes. In the current study, however, no correlation 
between the number and duration of inflations in the study 
group as a whole or in subgroups could be discerned. 
Furthermore, it is recognized that only by repeating 
angiography in every patient with an abnormal increase in 
enzyme levels could we exclude the few patients with 
postangioplasty silent or minor occurrences causing the 
increase. Such patients would have been incorrectly in-
cluded in the study group and classified as having no 
discernible cause of the increased serum level. However, it 
is unlikely that this sequence provides an explanation in 
most of these patients. 
Arora et al. (13) recently reported on the incidence of 
enzyme elevations and ECG changes along with the clinical 
sequelae in patients with side branch occlusion during cor-
onary angioplasty. They found that the maximal CK release 
was approximately 500 to 700 IV/liter, depending on the 
particular vessel and branch occluded. In general, ST 
changes occurred in the minority of cases, as did chest pain. 
In our study, only relatively small or medium-sized branches 
were occluded. Thus, our results demonstrate that when side 
branches do occlude as a part of an angioplasty procedure, 
there is a price to pay, albeit a small one. 
There are no existing studies that deal with the clinical 
sequelae of acute vessel occlusion during angioplasty that is 
reversed quickly during the course of the procedure. In our 
study, this particular event occurred in at least 11 (4%) of 249 
ultimately successful elective procedures. Additional cases 
occurred in our patients in whom no enzyme release was 
documented. Therefore, this complication appears to be 
relatively frequent and deserves further study. The inci-
dence of coronary spasm and thrombosis in this patient 
group is also similar to that previously reported. 
Conclusion. Transient CK and CK MB isoenzyme re-
lease can occur frequently in patients who meet the most 
rigorous existing standards for coronary angioplasty suc-
cess. In those cases where an actual event can be recognized 
to explain the enzyme release, a non-Q wave myocardial 
infarction probably occurred; in those cases where even a 
retrospective consideration fails to identify a cause, the 
precise meaning often remains uncertain. Although patient 
management and short-term prognosis are probably not 
directly altered, knowledge of the etiology of the event and 
coronary anatomy in conjunction with this information may 
be important. 
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